The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AVEO PHARMACEUTICALS INC | COM | 053588109 | 750 | 675,242 | SH | SOLE | 675,242 | 0 | 0 | ||
LIFELOCK INC | COM | 53224V100 | 148,319 | 10,379,241 | SH | SOLE | 10,379,241 | 0 | 0 | ||
MILLENNIAL MEDIA INC | COM | 60040N105 | 12,816 | 6,890,120 | SH | SOLE | 6,890,120 | 0 | 0 |